Sequoia Financial Advisors LLC Purchases 2,460 Shares of Koninklijke Philips N.V. $PHG

Sequoia Financial Advisors LLC raised its position in shares of Koninklijke Philips N.V. (NYSE:PHG) by 29.6% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,771 shares of the technology company’s stock after acquiring an additional 2,460 shares during the period. Sequoia Financial Advisors LLC’s holdings in Koninklijke Philips were worth $258,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the company. Fiduciary Management Inc. WI boosted its holdings in Koninklijke Philips by 21.7% during the first quarter. Fiduciary Management Inc. WI now owns 7,515,737 shares of the technology company’s stock valued at $190,900,000 after acquiring an additional 1,339,055 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Koninklijke Philips by 2.5% during the first quarter. Dimensional Fund Advisors LP now owns 4,396,095 shares of the technology company’s stock valued at $111,662,000 after buying an additional 106,044 shares during the last quarter. Northern Trust Corp raised its position in shares of Koninklijke Philips by 5.1% during the first quarter. Northern Trust Corp now owns 1,690,402 shares of the technology company’s stock valued at $42,936,000 after buying an additional 81,653 shares during the last quarter. Perpetual Ltd raised its position in shares of Koninklijke Philips by 2.6% during the second quarter. Perpetual Ltd now owns 872,646 shares of the technology company’s stock valued at $20,926,000 after buying an additional 21,898 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its position in shares of Koninklijke Philips by 1.5% during the first quarter. Goldman Sachs Group Inc. now owns 846,253 shares of the technology company’s stock valued at $21,495,000 after buying an additional 12,908 shares during the last quarter. 13.67% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research analysts have recently commented on the stock. Wall Street Zen lowered shares of Koninklijke Philips from a “buy” rating to a “hold” rating in a research report on Saturday, August 2nd. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Koninklijke Philips in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Koninklijke Philips currently has an average rating of “Moderate Buy”.

Koninklijke Philips Trading Up 0.5%

PHG stock opened at $28.55 on Thursday. Koninklijke Philips N.V. has a 1-year low of $21.48 and a 1-year high of $32.25. The firm has a market cap of $27.49 billion, a P/E ratio of 150.24, a P/E/G ratio of 0.77 and a beta of 0.82. The business’s 50 day moving average is $27.78 and its 200-day moving average is $25.45. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.69.

Koninklijke Philips (NYSE:PHG) last released its quarterly earnings data on Tuesday, July 29th. The technology company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.12. Koninklijke Philips had a return on equity of 11.95% and a net margin of 1.00%.The company had revenue of $5.05 billion for the quarter, compared to analyst estimates of $4.35 billion. Equities analysts anticipate that Koninklijke Philips N.V. will post 1.63 earnings per share for the current fiscal year.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.